Neuromyelitis Optica Spectrum Disorders Clinical Trials

40 clinical trials for Neuromyelitis Optica Spectrum Disorders across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD — RECRUITING
• Cohort Study on Neuroimmune Diseases in the Reproductive Age — RECRUITING
• Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder — RECRUITING · PHASE3
• A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) — RECRUITING · PHASE2
• The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders — RECRUITING · PHASE1
• Normal Chinese Lifespan Brain Charts Initiative (NCLBCI) — RECRUITING
• Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases — RECRUITING · PHASE1
• Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging — RECRUITING
• A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy — RECRUITING · PHASE1
• Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder — RECRUITING · NA
• Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis. — RECRUITING · NA
• A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD) — RECRUITING · PHASE2
• Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases — RECRUITING
• MS-ResearchBiomarkerS — RECRUITING
• Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial — NOT_YET_RECRUITING · PHASE4
• A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders — TERMINATED · PHASE3
• Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients — NOT_YET_RECRUITING
• Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy — NOT_YET_RECRUITING · PHASE1
• Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD — ACTIVE_NOT_RECRUITING · PHASE3
• Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility — COMPLETED
• Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD — NOT_YET_RECRUITING · PHASE3
• A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders — COMPLETED · PHASE1
• BLAZE-Limiting Approach in NMOSD — COMPLETED
• HANDLE-a Real World Study on Satralizumab in NMOSD — NOT_YET_RECRUITING
• Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System. — NOT_YET_RECRUITING · PHASE1
• Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE) — ACTIVE_NOT_RECRUITING · PHASE3
• A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD — COMPLETED · PHASE1
• A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders — OTHER · PHASE4
• Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders — OTHER
• Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study Protocol — COMPLETED · NA
• An Open Label Study of the Effects of SHR1459 in NMOSDs Patients — COMPLETED · PHASE2
• The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS) — COMPLETED
• An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit — COMPLETED
• Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders — COMPLETED · PHASE2
• Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders — OTHER
• The French Multiple Sclerosis Registry — OTHER
• Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders — OTHER
• Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients — OTHER · PHASE4
• Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders — OTHER · PHASE4

Refine this search